SCHEMBL26575341

SCHEMBL26575341

Cc1cccc(C)c1-c1cc(OCC(N)C(C(C)C)C(C)C)nc(NSc2cccc(C(=O)O)c2)n1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
SCN4A P35499 2/20 0.31
CYP1A2 P05177 2/20 0.31
NFKB1 P19838 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
THPO P40225 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MITF O75030 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
PAX8 Q06710 1/20 0.31
KLF5 Q13887 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26846380 0.91 SCN4A (0.34) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL22509294 0.88 AAK1 (0.34) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298810 0.88 AAK1 (0.34) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24323678 0.87 NR1H4 (0.33) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24324604 0.87 NR1H4 (0.32) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL26576986 0.86 LDHA (0.35) LDHALDHB
SCHEMBL24323223 0.85 SYK (0.32) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298126 0.85 SYK (0.32) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL26577890 0.85 MEN1 (0.30) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24324763 0.85 NPC1 (0.31) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196429-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-12 WO disclosed